Linearized DNA Manufacture

• Provide optimal solution for different projects

• Process 1.0 (high copy plasmid)

• ProPlus™ Process (low copy plasmid)

• ProSyn™ DNA Platform (PCV mRNA)

mRNA becomes to have wide applications for cancer, influenza, genetic diseases, etc. As a leading plasmid CDMO, ProBio offers three options in linearized DNA manufacturing for mRNA, aiming to help mRNA projects from preclinical to commercial stages with one-stop services.

To be specify, the plasmid from Process 1.0 and ProPlus^TM Process is still manufactured through e.coli fermentation, suitable for regular mRNA projects. However, in ProSyn^TM DNA Platform, the linearized DNA will be made through enzymatic DNA synthesis, means that clients can get small quantity of the product in fast turnaround time.

Contact us

Technical Platforms for Linearized DNA

Process 1.0

ProPlus^TM

ProSyn^TM DNA

• High copy plasmid: process 1.0

  • High density fermentation
  • Three-step purification
  • Plasmid manufacturing and QC release
  • Linearized DNA manufacturing and QC release

• Low copy plasmid: ProPlus^TM

  • High density fermentation
  • Compared to Process 1.0
  • Less purification steps, improving recovery rate
  • Final yield increases 2~3 times
  • No change for QC standard

• ProSyn^TM DNA Platform

  • RCA + enzyme digestion (non cell bank)
  • 10^-6~10^-7 low error rate
  • Primer Pool: stable structure and high universality

Linearized DNA Service

IND

Phase I

Phase II

Phase III

BLA

Commercial

IND CMC

GMPro^TM Grade

GMP Grade

BLA CMC

GMP Grade

Plasmid Manufacturing

Tech. Driven Platform for Plasmid as mRNA Template

• >10 global IND approvals (US, CN, JP, KR, ID, AE, etc.)
• Robust manufacturing process: multiple batches from mg to g
• Three manufacturing options: provide optimal solutions
• ProSyn^TM DNA platform: get small quantity GMP product in fast turnaround time

Related Service

• GMPro^TM Plasmid Manufacturing
• Plasmid CMC for IND
• Plasmid Manufacture
• mRNA Manufacture